Skip to main content
×
Home
About Us
Company Summary
Senior Management
The Board
Corporate Governance
Board Charter
Audit & Risk
Remuneration & Nominations
Code of Conduct
Continuous Disclosure
Risk Management
Shareholder Communication
Securities Trading
Board & Executive Evaluation
Diversity
Therapeutic Areas
Technology
MSCs
Immunotherapy
Sygenus
Product Pipeline
Pipeline Overview
Human Health
Progenza
Human Cancer Vaccine
Sygenus
Animal Health
CryoShot Canine
Kvax
Trials
Investors
ASX announcements
Financials
Analyst Coverage
Events & Presentations
Investor Relations Contact
Subscribe
News
2020
2019
2018
2017
2016
2015
2014
2013
Contact
Home
About Us
Company Summary
Senior Management
The Board
Corporate Governance
Therapeutic Areas
Technology
MSCs
Immunotherapy
Sygenus
Product Pipeline
Pipeline Overview
Human Health
Animal Health
Trials
Investors
ASX announcements
Financials
Analyst Coverage
Events & Presentations
Investor Relations Contact
Subscribe
News
2020
2019
2018
2017
2016
2015
2014
2013
Contact
Reports
Home
Investors
Reports
Reports
2020
2019
2018
2017
2016
2015
2014
2013
Date
Title
31/01/2020
Appendix 4C - Quarterly
